Intracranial hemorrhage following neuroendovascular procedures with abciximab is associated with high mortality: a multicenter series.

@article{Walsh2011IntracranialHF,
  title={Intracranial hemorrhage following neuroendovascular procedures with abciximab is associated with high mortality: a multicenter series.},
  author={Ryan D Walsh and Kevin M. Barrett and M I Aguilar and Giuseppe Lanzino and Ricardo A. Hanel and D. A. Miller and B. W. Chong and William David Freeman},
  journal={Neurocritical care},
  year={2011},
  volume={15 1},
  pages={85-95}
}
BACKGROUND Abciximab is being used as an adjunct to neuroendovascular procedures both to prevent and treat ischemic sequelae. Experience with abciximab in this setting is limited; major bleeding complications, including fatal intracranial hemorrhage (ICH), are of particular concern. We report our multicenter experience with ICH following the administration of abciximab during neuroendovascular procedures. METHODS We identified neuroendovascular procedures (including cerebral angiograms… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Similar Papers

Loading similar papers…